TW200815453A - Polymorphic forms and process - Google Patents

Polymorphic forms and process Download PDF

Info

Publication number
TW200815453A
TW200815453A TW096121905A TW96121905A TW200815453A TW 200815453 A TW200815453 A TW 200815453A TW 096121905 A TW096121905 A TW 096121905A TW 96121905 A TW96121905 A TW 96121905A TW 200815453 A TW200815453 A TW 200815453A
Authority
TW
Taiwan
Prior art keywords
soil
aryl
heteroaryl
doc
formula
Prior art date
Application number
TW096121905A
Other languages
English (en)
Chinese (zh)
Inventor
Kai Schiemann
Ulrich Emde
Tobias Schlueter
Christoph Saal
Michael Maiwald
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of TW200815453A publication Critical patent/TW200815453A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TW096121905A 2006-06-19 2007-06-15 Polymorphic forms and process TW200815453A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06012525 2006-06-19

Publications (1)

Publication Number Publication Date
TW200815453A true TW200815453A (en) 2008-04-01

Family

ID=38687475

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096121905A TW200815453A (en) 2006-06-19 2007-06-15 Polymorphic forms and process

Country Status (19)

Country Link
US (1) US8198452B2 (cg-RX-API-DMAC7.html)
EP (1) EP2032581B1 (cg-RX-API-DMAC7.html)
JP (1) JP5322928B2 (cg-RX-API-DMAC7.html)
KR (1) KR20090020702A (cg-RX-API-DMAC7.html)
CN (1) CN101472928A (cg-RX-API-DMAC7.html)
AR (1) AR061379A1 (cg-RX-API-DMAC7.html)
AU (1) AU2007263393B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0712393A2 (cg-RX-API-DMAC7.html)
CA (1) CA2656064C (cg-RX-API-DMAC7.html)
EA (1) EA015994B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP099077A (cg-RX-API-DMAC7.html)
ES (1) ES2537759T3 (cg-RX-API-DMAC7.html)
IL (1) IL195844A0 (cg-RX-API-DMAC7.html)
MX (1) MX2008016071A (cg-RX-API-DMAC7.html)
NZ (1) NZ574236A (cg-RX-API-DMAC7.html)
PE (1) PE20080337A1 (cg-RX-API-DMAC7.html)
TW (1) TW200815453A (cg-RX-API-DMAC7.html)
WO (1) WO2007147480A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200900383B (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005027170A1 (de) * 2005-06-13 2006-12-14 Merck Patent Gmbh Substituierte Tetrahydrochinoline
DE102007021862A1 (de) * 2007-05-10 2008-11-13 Merck Patent Gmbh Wässrige pharmazeutische Zubereitung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3345355A1 (de) * 1983-12-15 1985-06-27 Hoechst Ag, 6230 Frankfurt Verfahren zur racematspaltung bicyclischer imino-(alpha)-carbonsaeureester
DE4203547A1 (de) * 1992-02-07 1993-08-12 Knoll Ag Verfahren zur racemattrennung von verapamil
JPH07247286A (ja) * 1994-01-18 1995-09-26 Sankyo Co Ltd 含窒素環状化合物の光学分割方法
JPH07330732A (ja) * 1994-06-10 1995-12-19 Kyorin Pharmaceut Co Ltd 光学活性な3−アミノ−1−ベンジルピペリジン誘導体
GB0010437D0 (en) * 2000-04-28 2000-06-14 Darwin Discovery Ltd Process
US20040002615A1 (en) * 2002-06-28 2004-01-01 Allen David Robert Preparation of chiral amino-nitriles
DK1761515T3 (da) * 2003-12-20 2009-02-16 Merck Patent Gmbh 2-(hetero-)aryl-substituerede tetrahydroquinolinderivater

Also Published As

Publication number Publication date
WO2007147480A3 (en) 2008-05-08
AR061379A1 (es) 2008-08-20
EP2032581A2 (en) 2009-03-11
PE20080337A1 (es) 2008-04-25
WO2007147480A2 (en) 2007-12-27
JP2009541231A (ja) 2009-11-26
AU2007263393B2 (en) 2012-03-01
EA200802400A1 (ru) 2009-06-30
ZA200900383B (en) 2010-01-27
KR20090020702A (ko) 2009-02-26
BRPI0712393A2 (pt) 2012-10-16
NZ574236A (en) 2010-11-26
US20090176820A1 (en) 2009-07-09
EA015994B1 (ru) 2012-01-30
ES2537759T3 (es) 2015-06-11
CA2656064C (en) 2013-11-05
JP5322928B2 (ja) 2013-10-23
MX2008016071A (es) 2009-01-15
CA2656064A1 (en) 2007-12-27
ECSP099077A (es) 2009-02-27
EP2032581B1 (en) 2015-03-11
CN101472928A (zh) 2009-07-01
US8198452B2 (en) 2012-06-12
IL195844A0 (en) 2009-09-01
AU2007263393A1 (en) 2007-12-27

Similar Documents

Publication Publication Date Title
US11021486B2 (en) Coumarin-like cyclic compound as MEK inhibitor and use thereof
RU2270194C2 (ru) Бензофеноны как ингибиторы il-1бета и tnf-альфа, фармацевтическая композиция и способ лечения
KR101459401B1 (ko) 듀테로화 ω―디페닐우레아의 합성 및 생산방법과 단계
JPWO2002062775A1 (ja) 2−アシルアミノチアゾール誘導体又はその塩
TW200403224A (en) Novel compounds
CN102112465A (zh) 6-[(4s)-2-甲基-4-(2-萘基)-1,2,3,4-四氢异喹啉-7-基]哒嗪-3-胺的晶型
WO2017049992A1 (zh) Egfr激酶抑制剂及其制备方法和应用
KR20230104151A (ko) 아세트아미도-페닐테트라졸 유도체 및 그의 사용 방법
JPH11506772A (ja) 抗ウイルス化合物
CA2612495A1 (en) Hexahydro-pyrrolo-isoquinoline compounds for the treatment of cns disorders
CN112384493B (zh) 稠合三环γ-氨基酸衍生物的制备方法及中间体
JP2016505584A (ja) ダウン症候群及びアルツハイマー病に関連する認知欠損の治療のための、dyrk1aタンパク質阻害剤としての3,5−ジアリールアザインドール類
CN1578768A (zh) 邻氨基苯甲酰胺及其药学应用
JP5322928B2 (ja) 多形および方法
KR102614535B1 (ko) 중수소화 벤즈이미다졸 화합물 및 그의 의약 용도
CN119019379B (zh) 一种异呋喃酮类化合物及其药物组合物和用途
CN103796994A (zh) 哌嗪类衍生物及其制备方法以及在治疗胰岛素抵抗中的应用
CN102260187B (zh) 取代的氨甲酰基环己甲酸类化合物及其制法和用途
CA3090829A1 (en) Urea-substituted aromatic ring-linked dioxinoquinoline compounds, preparation method and uses thereof
CN119080738A (zh) 一种含肟结构的gspt1蛋白降解剂及其制备方法和应用
WO2024140671A1 (zh) 一种稠三环类衍生物、包含其的药物组合物及其用途
AU687414B2 (en) Piperidinyl substituted methanoanthracenes as D1/D2-antagonists and 5HT2-serotanin-antagonists
CN120040373A (zh) 一种噻唑类gpr52调节剂化合物
KR101464280B1 (ko) 클로라이드 채널 차단제로 유용한 화합물
CN116535424A (zh) 作为malt1抑制剂的三并环化合物及其药物组合物和应用